Literature DB >> 28843396

Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.

Maria Claudia Barrera1, Laura Jimena Rojas1, Austin Weiss2, Olga Fernandez1, Diane McMahon-Pratt3, Nancy G Saravia1, Maria Adelaida Gomez4.   

Abstract

The mechanisms of Leishmania resistance to antimonials have been primarily determined in experimentally derived Leishmania strains. However, their participation in the susceptibility phenotype in field isolates has not been conclusively established. Being an intracellular parasite, the activity of antileishmanials is dependent on internalization of drugs into host cells and effective delivery to the intracellular compartments inhabited by the parasite. In this study we quantified and comparatively analyzed the gene expression of nine molecules involved in mechanisms of xenobiotic detoxification and Leishmania resistance to antimonial drugs in resistant and susceptible laboratory derived and clinical L.(Viannia) panamensis strains(n=19). In addition, we explored the impact of Leishmania susceptibility to antimonials on the expression of macrophage gene products having putative functions in transport, accumulation and metabolism of antimonials. As previously shown for other Leishmania species, a trend of increased abcc3 and lower aqp-1 expression was observed in the laboratory derived Sb-resistant L.(V.) panamensis line. However, this was not found in clinical strains, in which the expression of abca2 was significantly higher in resistant strains as both, promastigotes and intracellular amastigotes. The effect of drug susceptibility on host cell gene expression was evaluated on primary human macrophages from patients with cutaneous leishmaniasis (n=17) infected ex-vivo with the matched L.(V.) panamensis strains isolated at diagnosis, and in THP-1 cells infected with clinical strains (n=6) and laboratory adapted L.(V.) panamensis lines. Four molecules, abcb1 (p-gp), abcb6, aqp-9 and mt2a were differentially modulated by drug resistant and susceptible parasites, and among these, a consistent and significantly increased expression of the xenobiotic scavenging molecule mt2a was observed in macrophages infected with Sb-susceptible L. (V.) panamensis. Our results substantiate that different mechanisms of drug resistance operate in laboratory adapted and clinical Leishmania strains, and provide evidence that parasite-mediated modulation of host cell gene expression of molecules involved in drug transport and metabolism could contribute to the mechanisms of drug resistance and susceptibility in Leishmania.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABC transporter; Aquaporin; Leishmania Viannia panamensis; Macrophage; Meglumine antimoniate

Mesh:

Substances:

Year:  2017        PMID: 28843396      PMCID: PMC5633519          DOI: 10.1016/j.actatropica.2017.08.017

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  51 in total

1.  Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials.

Authors:  Philippe Leprohon; Danielle Légaré; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

2.  Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals.

Authors:  J Liu; Y Liu; R A Goyer; W Achanzar; M P Waalkes
Journal:  Toxicol Sci       Date:  2000-06       Impact factor: 4.849

3.  Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.

Authors:  J D Chulay; L Fleckenstein; D H Smith
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

4.  In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.

Authors:  Karin Seifert; Patricia Escobar; Simon L Croft
Journal:  J Antimicrob Chemother       Date:  2010-01-20       Impact factor: 5.790

5.  Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.

Authors:  R Mukhopadhyay; S Dey; N Xu; D Gage; J Lightbody; M Ouellette; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia.

Authors:  Nancy Gore Saravia; Kristen Weigle; Claudia Navas; Iris Segura; Liliana Valderrama; Anais Zully Valencia; Blanca Escorcia; Diane McMahon-Pratt
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

7.  Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.

Authors:  Diego A Goyeneche-Patino; Liliana Valderrama; John Walker; Nancy G Saravia
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

8.  Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.

Authors:  T R Navin; B A Arana; F E Arana; J D Berman; J F Chajón
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

9.  Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.

Authors:  A Haimeur; M Ouellette
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.

Authors:  Maria Adelaida Gómez; Adriana Navas; Ricardo Márquez; Laura Jimena Rojas; Deninson Alejandro Vargas; Victor Manuel Blanco; Roni Koren; Dan Zilberstein; Nancy Gore Saravia
Journal:  J Antimicrob Chemother       Date:  2013-08-24       Impact factor: 5.790

View more
  7 in total

1.  Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony.

Authors:  Julián Medina; Lissa Cruz-Saavedra; Luz Helena Patiño; Marina Muñoz; Juan David Ramírez
Journal:  Parasit Vectors       Date:  2021-08-21       Impact factor: 3.876

2.  Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication.

Authors:  Luiza O R Pereira; Cíntia S Sousa; Hellen C P Ramos; Eduardo C Torres-Santos; Liliane S Pinheiro; Marcelo R Alves; Patricia Cuervo; Gustavo A Sierra Romero; Mariana C Boité; Renato Porrozzi; Elisa Cupolillo
Journal:  Parasit Vectors       Date:  2021-10-28       Impact factor: 3.876

3.  Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing.

Authors:  J Eduardo Martinez-Hernandez; Zaynab Hammoud; Alessandra Mara de Sousa; Frank Kramer; Rubens L do Monte-Neto; Vinicius Maracaja-Coutinho; Alberto J M Martin
Journal:  Microbiol Spectr       Date:  2021-10-20

4.  Transcriptome Analysis of Intracellular Amastigotes of Clinical Leishmania infantum Lines from Therapeutic Failure Patients after Infection of Human Macrophages.

Authors:  Raquel García-Hernández; Ana Perea-Martínez; José Ignacio Manzano; Laura C Terrón-Camero; Eduardo Andrés-León; Francisco Gamarro
Journal:  Microorganisms       Date:  2022-06-27

5.  MRPA-independent mechanisms of antimony resistance in Leishmania infantum.

Authors:  Noélie Douanne; Victoria Wagner; Gaetan Roy; Philippe Leprohon; Marc Ouellette; Christopher Fernandez-Prada
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-04-02       Impact factor: 4.077

6.  High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.

Authors:  Christopher Fernandez-Prada; Mansi Sharma; Marie Plourde; Eva Bresson; Gaétan Roy; Philippe Leprohon; Marc Ouellette
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-16       Impact factor: 4.077

7.  Evolution, function and roles in drug sensitivity of trypanosome aquaglyceroporins.

Authors:  Juan F Quintana; Mark C Field
Journal:  Parasitology       Date:  2021-02-19       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.